The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark

Background: The European Medicine Agency (EMA) provided additional recommendations regarding the use of valproate during pregnancy in 2018 by introducing a pregnancy prevention program (PPP). This study aimed to investigate the adherence and the impact of the PPP and the awareness of valproate terat...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveri, Nadia Maria Barbara, Hansen, Johanne Mølby, Almarsdóttir, Anna Birna, Jacobsen, Ramune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915910/
https://www.ncbi.nlm.nih.gov/pubmed/36767582
http://dx.doi.org/10.3390/ijerph20032215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915910/
https://www.ncbi.nlm.nih.gov/pubmed/36767582
http://dx.doi.org/10.3390/ijerph20032215

Ejemplares similares